Novo Nordisk (NVO) Stock Highlights

85 | -17.83%

2024-12-21 00:01:49

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Statistics

Range Today

81.5 86.53

Volume Today 52.68M

Range 1 Year

99.42 148.15

Volume 1 Year 1.13B

Range 3 Year

45.76 148.15

Volume 3 Year 2.75B

Range 10 Year

15.44 148.15

Volume 10 Year 8.45B

Highlights

Market Capitalization 396.19B (mega)

Floating Shares 3.19B

Current Price 85

Price To Earnings 27.76

Price To Revenue 1.64

Price To Book 3.14

Earnings Per Share 2.98

Dividend Yield 1.4%

Dividend Per Share 1.45

Payout Ratio 46.73%

Performance

Latest -17.83%

1 Month -17.82%

3 Months -34.16%

6 Months -39.93%

1 Year -16.01%

3 Years +63.27%

5 Years +193%

10 Years +288.31%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.